{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:59:25Z","timestamp":1793393965638,"version":"4.5.0"},"reference-count":175,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Medulloblastoma (MB) is a highly malignant childhood tumor of the cerebellum. Transcriptional and epigenetic signatures have classified MB into four molecular subgroups, further stratified into biologically different subtypes with distinct somatic copy-number aberrations, driver genes, epigenetic alterations, activated pathways, and clinical outcomes. The brain tumor microenvironment (BTME) is of importance to regulate a complex network of cells, including immune cells, involved in cancer progression in brain malignancies. MB was considered with a \u201ccold\u201d immunophenotype due to the low influx of immune cells across the blood brain barrier (BBB). Recently, this assumption has been reconsidered because of the identification of infiltrating immune cells showing immunosuppressive phenotypes in the BTME of MB tumors. Here, we are providing a comprehensive overview of the current status of epigenetics alterations occurring during cancer progression with a description of the genomic landscape of MB by focusing on immune cells within the BTME. We further describe how new immunotherapeutic approaches could influence concurring epigenetic mechanisms of the immunosuppressive cells in BTME. In conclusion, the modulation of these molecular genetic complexes in BTME during cancer progression might enhance the therapeutic benefit, thus firing new weapons to fight MB.<\/jats:p>","DOI":"10.3389\/fgene.2023.1135404","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T23:36:33Z","timestamp":1678404993000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Epigenetics and immune cells in medulloblastoma"],"prefix":"10.3389","volume":"14","author":[{"given":"Francesca","family":"Gorini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasqualino","family":"de Antonellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Amente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Zollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1189\/jlb.1012531","article-title":"Targeted STAT3 disruption in myeloid cells alters immunosuppressor cell abundance in a murine model of spontaneous medulloblastoma","volume":"95","author":"Abad","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"670","DOI":"10.4252\/wjsc.v13.i7.670","article-title":"Epigenetic modulators for brain cancer stem cells: Implications for anticancer treatment","volume":"13","author":"Abballe","year":"2021","journal-title":"World J. Stem Cells"},{"key":"B3","doi-asserted-by":"publisher","first-page":"10204","DOI":"10.1038\/ncomms10204","article-title":"Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts","volume":"6","author":"Albrengues","year":"2015","journal-title":"Nat. Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/ijc.27455","article-title":"Targeting the enhancer of zeste homologue 2 in medulloblastoma","volume":"131","author":"Alimova","year":"2012","journal-title":"Int. J. Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"101250","DOI":"10.1016\/j.isci.2020.101250","article-title":"A structurally simple vaccine candidate reduces progression and dissemination of triple-negative breast cancer","volume":"23","author":"Amedei","year":"2020","journal-title":"iScience"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1038\/s41467-021-22885-8","article-title":"Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas","volume":"12","author":"Amoozgar","year":"2021","journal-title":"Nat. Commun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10637-016-0401-4","article-title":"The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma","volume":"35","author":"Andrade","year":"2017","journal-title":"Invest. New Drugs"},{"key":"B8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bcp.2017.04.016","article-title":"Selective inhibition of EZH2 by a small molecule inhibitor regulates microglial gene expression essential for inflammation","volume":"137","author":"Arifuzzaman","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11864-021-00874-9","article-title":"Immunosuppression in medulloblastoma: Insights into cancer immunity and immunotherapy","volume":"22","author":"Audi","year":"2021","journal-title":"Curr. Treat. Options Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1172\/JCI57147","article-title":"Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target","volume":"121","author":"Baryawno","year":"2011","journal-title":"J. Clin. Invest."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1002\/ijc.30256","article-title":"OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models","volume":"139","author":"Berenguer-Daize","year":"2016","journal-title":"Int. J. Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"758146","DOI":"10.3389\/fonc.2021.758146","article-title":"Functional genomics of PRUNE1 in neurodevelopmental disorders (NDDs) tied to medulloblastoma (MB) and other tumors","volume":"11","author":"Bibbo","year":"2021","journal-title":"Front. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1462430","DOI":"10.1080\/2162402X.2018.1462430","article-title":"Subgroup-specific immune and stromal microenvironment in medulloblastoma","volume":"7","author":"Bockmayr","year":"2018","journal-title":"Oncoimmunology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature04733","article-title":"Polycomb complexes repress developmental regulators in murine embryonic stem cells","volume":"441","author":"Boyer","year":"2006","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00401-012-1069-2","article-title":"OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels","volume":"125","author":"Bunt","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2013","article-title":"Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation","volume":"12","author":"Canettieri","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1002\/eji.200737546","article-title":"Both CD133+ and CD133-medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity","volume":"37","author":"Castriconi","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccell.2017.05.005","article-title":"Intertumoral heterogeneity within medulloblastoma subgroups","volume":"31","author":"Cavalli","year":"2017","journal-title":"Cancer Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1038\/bcj.2013.38","article-title":"Pomalidomide: The new immunomodulatory agent for the treatment of multiple myeloma","volume":"3","author":"Chanan-Khan","year":"2013","journal-title":"Blood Cancer J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1158\/0008-5472.CAN-16-0144","article-title":"CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells","volume":"76","author":"Chang","year":"2016","journal-title":"Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.neo.2020.04.001","article-title":"LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase","volume":"22","author":"Chen","year":"2020","journal-title":"Neoplasia"},{"key":"B23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: An accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.toxlet.2013.12.023","article-title":"SOCS1 hypermethylation mediated by DNMT1 is associated with lipopolysaccharide-induced inflammatory cytokines in macrophages","volume":"225","author":"Cheng","year":"2014","journal-title":"Toxicol. Lett."},{"key":"B25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fncel.2018.00243","article-title":"Epigenetics control microglia plasticity","volume":"12","author":"Cheray","year":"2018","journal-title":"Front. Cell Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"20395","DOI":"10.1074\/jbc.M701574200","article-title":"PTIP associates with MLL3-and MLL4-containing histone H3 lysine 4 methyltransferase complex","volume":"282","author":"Cho","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"108917","DOI":"10.1016\/j.celrep.2021.108917","article-title":"Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality","volume":"34","author":"Dang","year":"2021","journal-title":"Cell Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"6554","DOI":"10.1038\/s41598-017-06914-5","article-title":"RNA sequencing reveals resistance of TLR4 ligand-activated microglial cells to inflammation mediated by the selective jumonji H3K27 demethylase inhibitor","volume":"7","author":"Das","year":"2017","journal-title":"Sci. Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1593\/neo.101630","article-title":"Identification and characterization of KCASH2 and KCASH3, 2 novel Cullin3 adaptors suppressing histone deacetylase and Hedgehog activity in medulloblastoma","volume":"13","author":"De Smaele","year":"2011","journal-title":"Neoplasia"},{"key":"B30","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1158\/1535-7163.MCT-14-0481","article-title":"Histone deacetylase 6 represents a novel drug target in the oncogenic Hedgehog signaling pathway","volume":"14","author":"Dhanyamraju","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3892\/ol.2020.12260","article-title":"Immune cell infiltration and cytokine secretion analysis reveal a non-inflammatory microenvironment of medulloblastoma","volume":"20","author":"Diao","year":"2020","journal-title":"Oncol. Lett."},{"key":"B32","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00401-012-1070-9","article-title":"Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma","volume":"125","author":"Dubuc","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1101\/gad.349538.122","article-title":"Coming in from the cold: Overcoming the hostile immune microenvironment of medulloblastoma","volume":"36","author":"Eisemann","year":"2022","journal-title":"Genes Dev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00401-010-0726-6","article-title":"Childhood medulloblastoma: Novel approaches to the classification of a heterogeneous disease","volume":"120","author":"Ellison","year":"2010","journal-title":"Acta Neuropathol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"7951","DOI":"10.1200\/JCO.2005.01.5479","article-title":"beta-catenin status predicts a favorable outcome in childhood medulloblastoma: The United Kingdom Children's cancer study group brain tumour committee","volume":"23","author":"Ellison","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11060-015-1979-7","article-title":"Pediatric brain tumors in a low\/middle income country: Does it differ from that in developed world?","volume":"126","author":"Ezzat","year":"2016","journal-title":"J. Neurooncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-019-0811-9","article-title":"LSD1\/KDM1A inhibitors in clinical trials: Advances and prospects","volume":"12","author":"Fang","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"660892","DOI":"10.3389\/fonc.2021.660892","article-title":"Phase 2 study of pomalidomide (CC-4047) monotherapy for children and young adults with recurrent or progressive primary brain tumors","volume":"11","author":"Fangusaro","year":"2021","journal-title":"Front. Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fonc.2013.00094","article-title":"In vitro natural killer cell immunotherapy for medulloblastoma","volume":"3","author":"Fernandez","year":"2013","journal-title":"Front. Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"101938","DOI":"10.1016\/j.isci.2020.101938","article-title":"Prune-1 drives polarization of tumor-associated macrophages (TAMs) within the lung metastatic niche in triple-negative breast cancer","volume":"24","author":"Ferrucci","year":"2021","journal-title":"iScience"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/brain\/awy039","article-title":"Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-beta-OTX2-SNAIL via PTEN inhibition","volume":"141","author":"Ferrucci","year":"2018","journal-title":"Brain"},{"key":"B43","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S1470-2045(06)70867-1","article-title":"Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (st jude medulloblastoma-96): Long-term results from a prospective, multicentre trial","volume":"7","author":"Gajjar","year":"2006","journal-title":"Lancet Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.cell.2018.05.033","article-title":"A hematogenous route for medulloblastoma leptomeningeal metastases","volume":"173","author":"Garzia","year":"2018","journal-title":"Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"E3458","DOI":"10.1073\/pnas.1412489111","article-title":"T-cell TGF-beta signaling abrogation restricts medulloblastoma progression","volume":"111","author":"Gate","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.2217\/imt.11.131","article-title":"Use of allogeneic NK cells for cancer immunotherapy","volume":"3","author":"Geller","year":"2011","journal-title":"Immunotherapy"},{"key":"B47","doi-asserted-by":"publisher","first-page":"eaaf2968","DOI":"10.1126\/scitranslmed.aaf2968","article-title":"Disrupting the CD47-SIRP\u03b1 anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors","volume":"9","author":"Gholamin","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/nature09587","article-title":"Subtypes of medulloblastoma have distinct developmental origins","volume":"468","author":"Gibson","year":"2010","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: Mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1097\/MPH.0000000000001339","article-title":"Nivolumab in the treatment of recurrent or refractory pediatric brain tumors: A single institutional experience","volume":"41","author":"Gorsi","year":"2019","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/S1470-2045(18)30532-1","article-title":"Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT\/non-SHH medulloblastoma: A retrospective, molecular analysis of the HIT-SIOP PNET 4 trial","volume":"19","author":"Goschzik","year":"2018","journal-title":"Lancet Oncol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1038\/s41467-020-18070-y","article-title":"Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity","volume":"11","author":"Grabovska","year":"2020","journal-title":"Nat. Commun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrg3173","article-title":"Histone methylation: A dynamic mark in health, disease and inheritance","volume":"13","author":"Greer","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s00262-017-2051-6","article-title":"Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11)","volume":"66","author":"Gururangan","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1080\/15384047.2016.1250047","article-title":"NKG2D ligand expression in pediatric brain tumors","volume":"17","author":"Haberthur","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1038\/onc.2009.161","article-title":"Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8","volume":"28","author":"Hacker","year":"2009","journal-title":"Oncogene"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1038\/onc.2010.599","article-title":"Histone deacetylase inhibitors prime medulloblastoma cells for chemotherapy-induced apoptosis by enhancing p53-dependent Bax activation","volume":"30","author":"Hacker","year":"2011","journal-title":"Oncogene"},{"key":"B58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/diseases7040057","article-title":"Histone deacetylases and their inhibitors in cancer epigenetics","volume":"7","author":"Hassell","year":"2019","journal-title":"Diseases"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s41586-022-05215-w","article-title":"Failure of human rhombic lip differentiation underlies medulloblastoma formation","volume":"609","author":"Hendrikse","year":"2022","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.18632\/oncotarget.1534","article-title":"BET bromodomain protein inhibition is a therapeutic option for medulloblastoma","volume":"4","author":"Henssen","year":"2013","journal-title":"Oncotarget"},{"key":"B61","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1101\/gad.191163.112","article-title":"A complex polycomb issue: The two faces of EZH2 in cancer","volume":"26","author":"Hock","year":"2012","journal-title":"Genes Dev."},{"key":"B62","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature13268","article-title":"Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing","volume":"510","author":"Hovestadt","year":"2014","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13148-021-01154-x","article-title":"DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: Mechanism and clinical application","volume":"13","author":"Hu","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"B64","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/pro.3142","article-title":"Stepwise assembly of functional C-terminal REST\/NRSF transcriptional repressor complexes as a drug target","volume":"26","author":"Inui","year":"2017","journal-title":"Protein Sci."},{"key":"B65","first-page":"6108","article-title":"MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors","volume":"62","author":"Jaboin","year":"2002","journal-title":"Cancer Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1200\/JCO.2011.40.2792","article-title":"Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: A Children's oncology group phase I\/II study","volume":"30","author":"Jakacki","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/s41588-019-0531-7","article-title":"Stalled developmental programs at the root of pediatric brain tumors","volume":"51","author":"Jessa","year":"2019","journal-title":"Nat. Genet."},{"key":"B68","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/emboj.2010.318","article-title":"Distinct roles of GCN5\/PCAF-mediated H3K9ac and CBP\/p300-mediated H3K18\/27ac in nuclear receptor transactivation","volume":"30","author":"Jin","year":"2011","journal-title":"EMBO J."},{"key":"B69","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature11284","article-title":"Dissecting the genomic complexity underlying medulloblastoma","volume":"488","author":"Jones","year":"2012","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/bpa.12019","article-title":"The role of chromatin remodeling in medulloblastoma","volume":"23","author":"Jones","year":"2013","journal-title":"Brain Pathol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/neuonc\/noab030","article-title":"Clinical features, neurologic recovery, and risk factors of postoperative posterior fossa syndrome and delayed recovery: A prospective study","volume":"23","author":"Khan","year":"2021","journal-title":"Neuro Oncol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.mrfmmm.2007.06.005","article-title":"Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells","volume":"625","author":"Khaw","year":"2007","journal-title":"Mutat. Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e78045","DOI":"10.1371\/journal.pone.0078045","article-title":"Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes","volume":"8","author":"Kittan","year":"2013","journal-title":"PLoS One"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","article-title":"Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells","volume":"181","author":"Klemm","year":"2020","journal-title":"Cell"},{"key":"B75","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00401-012-0958-8","article-title":"Molecular subgroups of medulloblastoma: An international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomas","volume":"123","author":"Kool","year":"2012","journal-title":"Acta Neuropathol."},{"key":"B76","first-page":"465","article-title":"Histone deacetylase inhibitors, but not vincristine, cooperate with radiotherapy to induce cell death in medulloblastoma","volume":"27","author":"Kumar","year":"2007","journal-title":"Anticancer Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4049\/jimmunol.182.1.259","article-title":"Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation","volume":"182","author":"Lal","year":"2009","journal-title":"J. Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41467-018-08269-5","article-title":"Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma","volume":"10","author":"Lee","year":"2019","journal-title":"Nat. Commun."},{"key":"B79","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1126\/science.1149042","article-title":"Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination","volume":"318","author":"Lee","year":"2007","journal-title":"Science"},{"key":"B80","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.cell.2006.02.043","article-title":"Control of developmental regulators by Polycomb in human embryonic stem cells","volume":"125","author":"Lee","year":"2006","journal-title":"Cell"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1158\/1535-7163.MCT-05-0184","article-title":"Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC","volume":"4","author":"Li","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"B82","doi-asserted-by":"publisher","first-page":"a026831","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC inhibitors in cancer development and therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"e71754","DOI":"10.1371\/journal.pone.0071754","article-title":"Pomalidomide shows significant therapeutic activity against CNS lymphoma with a major impact on the tumor microenvironment in murine models","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"B84","doi-asserted-by":"publisher","first-page":"103808","DOI":"10.1016\/j.bioorg.2020.103808","article-title":"New tranylcypromine derivatives containing sulfonamide motif as potent LSD1 inhibitors to target acute myeloid leukemia: Design, synthesis and biological evaluation","volume":"99","author":"Liang","year":"2020","journal-title":"Bioorg Chem."},{"key":"B85","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature16546","article-title":"Active medulloblastoma enhancers reveal subgroup-specific cellular origins","volume":"530","author":"Lin","year":"2016","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1038\/onc.2014.405","article-title":"Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenance","volume":"34","author":"Lindsey","year":"2015","journal-title":"Oncogene"},{"key":"B87","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neulet.2017.02.076","article-title":"Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma","volume":"645","author":"Lisi","year":"2017","journal-title":"Neurosci. Lett."},{"key":"B88","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/neuonc\/noz214","article-title":"Necroptotic astrocytes contribute to maintaining stemness of disseminated medulloblastoma through CCL2 secretion","volume":"22","author":"Liu","year":"2020","journal-title":"Neuro Oncol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/path.4832","article-title":"Understanding the epigenetic regulation of tumours and their microenvironments: Opportunities and problems for epigenetic therapy","volume":"241","author":"Liu","year":"2017","journal-title":"J. Pathol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"6050","DOI":"10.1182\/blood-2011-05-354449","article-title":"Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma","volume":"118","author":"Louis","year":"2011","journal-title":"Blood"},{"key":"B91","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: A summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B92","first-page":"5906","article-title":"Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development","volume":"62","author":"Lusher","year":"2002","journal-title":"Cancer Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1158\/1078-0432.CCR-14-1144","article-title":"Tumor-associated macrophages in SHH subgroup of medulloblastomas","volume":"21","author":"Margol","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.2217\/epi-2016-0110","article-title":"Epigenetic control of the tumor microenvironment","volume":"8","author":"Marks","year":"2016","journal-title":"Epigenomics"},{"key":"B95","doi-asserted-by":"publisher","first-page":"845","DOI":"10.4049\/jimmunol.179.2.845","article-title":"Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cells","volume":"179","author":"Masson","year":"2007","journal-title":"J. Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/15592294.2016.1278095","article-title":"Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies","volume":"12","author":"Maury","year":"2017","journal-title":"Epigenetics"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1038\/s41467-019-10458-9","article-title":"Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma","volume":"10","author":"Maximov","year":"2019","journal-title":"Nat. Commun."},{"key":"B98","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13148-017-0358-y","article-title":"Epi-drugs in combination with immunotherapy: A new avenue to improve anticancer efficacy","volume":"9","author":"Mazzone","year":"2017","journal-title":"Clin. Epigenetics"},{"key":"B99","doi-asserted-by":"publisher","first-page":"68557","DOI":"10.18632\/oncotarget.19782","article-title":"The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells","volume":"8","author":"Miele","year":"2017","journal-title":"Oncotarget"},{"key":"B100","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11060-012-0978-1","article-title":"HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment","volume":"110","author":"Milde","year":"2012","journal-title":"J. Neurooncol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-022-02522-4","article-title":"Identification of low and very high-risk patients with non-WNT\/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts","volume":"145","author":"Mynarek","year":"2022","journal-title":"Acta Neuropathol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11060-015-1890-2","article-title":"Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma","volume":"125","author":"Nair","year":"2015","journal-title":"J. Neurooncol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40425-018-0340-z","article-title":"Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells","volume":"6","author":"Nellan","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"B104","doi-asserted-by":"publisher","first-page":"836223","DOI":"10.3389\/fimmu.2022.836223","article-title":"Epigenetic modifications in tumor-associated macrophages: A new perspective for an old foe","volume":"13","author":"Niu","year":"2022","journal-title":"Front. Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature22973","article-title":"The whole-genome landscape of medulloblastoma subtypes","volume":"547","author":"Northcott","year":"2017","journal-title":"Nature"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1200\/JCO.2009.27.4324","article-title":"Medulloblastoma comprises four distinct molecular variants","volume":"29","author":"Northcott","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature13379","article-title":"Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma","volume":"511","author":"Northcott","year":"2014","journal-title":"Nature"},{"key":"B108","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ng.336","article-title":"Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma","volume":"41","author":"Northcott","year":"2009","journal-title":"Nat. Genet."},{"key":"B109","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-019-0063-6","article-title":"Medulloblastoma","volume":"5","author":"Northcott","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B110","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrg2957","article-title":"Enhancer function: New insights into the regulation of tissue-specific gene expression","volume":"12","author":"Ong","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"B111","first-page":"130","article-title":"Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma","volume":"7","author":"Packer","year":"2007","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/neuonc\/noz089","article-title":"A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma","volume":"21","author":"Pak","year":"2019","journal-title":"Neuro Oncol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.3389\/fimmu.2019.02294","article-title":"Microenvironmental heterogeneity in brain malignancies","volume":"10","author":"Perus","year":"2019","journal-title":"Front. Immunol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3390\/biom11020306","article-title":"Epigenetics and communication mechanisms in microglia activation with a view on technological approaches","volume":"11","author":"Petralla","year":"2021","journal-title":"Biomolecules"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/ijc.23283","article-title":"The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma","volume":"122","author":"Pfister","year":"2008","journal-title":"Int. J. Cancer"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/nar\/gkm094","article-title":"Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma","volume":"35","author":"Pfister","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"B117","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1158\/1078-0432.CCR-15-0713","article-title":"Differential immune microenvironments and response to immune checkpoint blockade among molecular subtypes of murine medulloblastoma","volume":"22","author":"Pham","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ccell.2016.03.002","article-title":"Medulloblastoma genotype dictates blood brain barrier phenotype","volume":"29","author":"Phoenix","year":"2016","journal-title":"Cancer Cell"},{"key":"B119","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/d41586-022-02951-x","article-title":"The origins of medulloblastoma tumours in humans","volume":"609","author":"Phoenix","year":"2022","journal-title":"Nature"},{"key":"B120","doi-asserted-by":"publisher","first-page":"10714","DOI":"10.1523\/JNEUROSCI.1922-07.2007","article-title":"CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells","volume":"27","author":"Ponomarev","year":"2007","journal-title":"J. Neurosci."},{"key":"B121","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12967-019-2055-4","article-title":"Medulloblastoma rendered susceptible to NK-cell attack by TGF\u03b2 neutralization","volume":"17","author":"Powell","year":"2019","journal-title":"J. Transl. Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature11329","article-title":"Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations","volume":"488","author":"Pugh","year":"2012","journal-title":"Nature"},{"key":"B123","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"B125","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nrc3929","article-title":"Hijacked in cancer: The KMT2 (MLL) family of methyltransferases","volume":"15","author":"Rao","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"B126","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2011.12.013","article-title":"Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations","volume":"148","author":"Rausch","year":"2012","journal-title":"Cell"},{"key":"B127","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/neuonc\/noab135","article-title":"Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma","volume":"24","author":"Riemondy","year":"2022","journal-title":"Neuro Oncol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature11213","article-title":"Novel mutations target distinct subgroups of medulloblastoma","volume":"488","author":"Robinson","year":"2012","journal-title":"Nature"},{"key":"B129","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.celrep.2017.09.018","article-title":"Prostaglandin E2 leads to the acquisition of dnmt3a-dependent tolerogenic functions in human myeloid-derived suppressor cells","volume":"21","author":"Rodriguez-Ubreva","year":"2017","journal-title":"Cell Rep."},{"key":"B130","first-page":"3794","article-title":"Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma","volume":"62","author":"Rood","year":"2002","journal-title":"Cancer Res."},{"key":"B131","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12311-017-0899-9","article-title":"Epigenetic drivers in pediatric medulloblastoma","volume":"17","author":"Roussel","year":"2018","journal-title":"Cerebellum"},{"key":"B132","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4103\/abr.abr_142_19","article-title":"Histone deacetylases and histone deacetylase inhibitors: Molecular mechanisms of action in various cancers","volume":"8","author":"Sanaei","year":"2019","journal-title":"Adv. Biomed. Res."},{"key":"B133","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/ni.1920","article-title":"The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection","volume":"11","author":"Satoh","year":"2010","journal-title":"Nat. Immunol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.cell.2007.02.009","article-title":"Genome regulation by polycomb and trithorax proteins","volume":"128","author":"Schuettengruber","year":"2007","journal-title":"Cell"},{"key":"B135","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S1470-2045(17)30243-7","article-title":"Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: A cohort study","volume":"18","author":"Schwalbe","year":"2017","journal-title":"Lancet Oncol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00401-012-1077-2","article-title":"DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies","volume":"125","author":"Schwalbe","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"key":"B138","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11060-010-0401-8","article-title":"Human hedgehog interacting protein expression and promoter methylation in medulloblastoma cell lines and primary tumor samples","volume":"103","author":"Shahi","year":"2011","journal-title":"J. Neurooncol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1186\/1471-2407-10-614","article-title":"Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, Cyclin D2, Plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma","volume":"10","author":"Shahi","year":"2010","journal-title":"BMC Cancer"},{"key":"B140","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00401-019-02020-0","article-title":"Second-generation molecular subgrouping of medulloblastoma: An international meta-analysis of group 3 and group 4 subtypes","volume":"138","author":"Sharma","year":"2019","journal-title":"Acta Neuropathol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41586-022-05208-9","article-title":"Unified rhombic lip origins of group 3 and group 4 medulloblastoma","volume":"609","author":"Smith","year":"2022","journal-title":"Nature"},{"key":"B142","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3892\/ijo.28.3.755","article-title":"Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells","volume":"28","author":"Sonnemann","year":"2006","journal-title":"Int. J. Oncol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10585-012-9457-5","article-title":"Tumor microenvironment: A main actor in the metastasis process","volume":"29","author":"Spano","year":"2012","journal-title":"Clin. Exp. Metastasis"},{"key":"B144","doi-asserted-by":"publisher","first-page":"9211","DOI":"10.1158\/0008-5472.CAN-09-1622","article-title":"EZH2 is essential for glioblastoma cancer stem cell maintenance","volume":"69","author":"Suva","year":"2009","journal-title":"Cancer Res."},{"key":"B145","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2217\/epi-2019-0165","article-title":"Epigenetic mechanisms driving tumor supportive microenvironment differentiation and function: A role in cancer therapy?","volume":"12","author":"Sylvestre","year":"2020","journal-title":"Epigenomics"},{"key":"B146","doi-asserted-by":"publisher","first-page":"a026427","DOI":"10.1101\/cshperspect.a026427","article-title":"MLL3\/MLL4\/COMPASS family on epigenetic regulation of enhancer function and cancer","volume":"6","author":"Sze","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B147","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41388-020-01536-0","article-title":"CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model","volume":"40","author":"Tan","year":"2021","journal-title":"Oncogene"},{"key":"B148","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nm.3613","article-title":"Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition","volume":"20","author":"Tang","year":"2014","journal-title":"Nat. Med."},{"key":"B149","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2013.159","article-title":"Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson's disease","volume":"21","author":"Tang","year":"2014","journal-title":"Cell Death Differ."},{"key":"B150","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","article-title":"Molecular subgroups of medulloblastoma: The current consensus","volume":"123","author":"Taylor","year":"2012","journal-title":"Acta Neuropathol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"157","DOI":"10.21037\/tp.2020.03.03","article-title":"Current medulloblastoma subgroup specific clinical trials","volume":"9","author":"Thompson","year":"2020","journal-title":"Transl. Pediatr."},{"key":"B152","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/jnen\/nly045","article-title":"Poliovirus receptor (CD155) expression in pediatric brain tumors mediates oncolysis of medulloblastoma and pleomorphic xanthoastrocytoma","volume":"77","author":"Thompson","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1470-2045(15)00581-1","article-title":"Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: A retrospective integrated clinical and molecular analysis","volume":"17","author":"Thompson","year":"2016","journal-title":"Lancet Oncol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.3390\/cancers14205009","article-title":"The tumor microenvironment of medulloblastoma: An intricate multicellular network with therapeutic potential","volume":"14","author":"van Bree","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B155","doi-asserted-by":"publisher","first-page":"e1398877","DOI":"10.1080\/2162402X.2017.1398877","article-title":"Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma","volume":"7","author":"Vermeulen","year":"2018","journal-title":"Oncoimmunology"},{"key":"B156","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1215\/15228517-2006-038","article-title":"Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma","volume":"9","author":"Vibhakar","year":"2007","journal-title":"Neuro Oncol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s41591-021-01404-8","article-title":"Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: An interim analysis","volume":"27","author":"Vitanza","year":"2021","journal-title":"Nat. Med."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/carcin\/bgv146","article-title":"Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts","volume":"36","author":"Vizoso","year":"2015","journal-title":"Carcinogenesis"},{"key":"B159","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1016\/j.celrep.2017.02.073","article-title":"Inactivation of Ezh2 upregulates Gfi1 and drives aggressive myc-driven group 3 medulloblastoma","volume":"18","author":"Vo","year":"2017","journal-title":"Cell Rep."},{"key":"B160","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1200\/JCO.2016.67.2428","article-title":"Treatment of children and adolescents with metastatic medulloblastoma and prognostic relevance of clinical and biologic parameters","volume":"34","author":"von Bueren","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"e620","DOI":"10.7759\/cureus.620","article-title":"Bromodomain inhibitor review: Bromodomain and extra-terminal family protein inhibitors as a potential new therapy in central nervous system tumors","volume":"8","author":"Wadhwa","year":"2016","journal-title":"Cureus"},{"key":"B177","doi-asserted-by":"publisher","first-page":"111162","DOI":"10.1016\/j.celrep.2022.111162","article-title":"Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development","volume":"40","author":"Williamson","year":"2022","journal-title":"Cell Rep."},{"key":"B162","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat. Genet."},{"key":"B163","doi-asserted-by":"publisher","first-page":"11013","DOI":"10.3390\/ijms150611013","article-title":"Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells","volume":"15","author":"Yang","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"B164","doi-asserted-by":"publisher","first-page":"640369","DOI":"10.3389\/fimmu.2021.640369","article-title":"Role of epigenetic regulation in plasticity of tumor immune microenvironment","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Immunol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccr.2008.07.003","article-title":"Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells","volume":"14","author":"Yang","year":"2008","journal-title":"Cancer Cell"},{"key":"B166","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.cell.2019.12.024","article-title":"Astrocytic trans-differentiation completes a multicellular paracrine feedback loop required for medulloblastoma tumor growth","volume":"180","author":"Yao","year":"2020","journal-title":"Cell"},{"key":"B167","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mcn.2017.09.003","article-title":"Epigenetic regulation in medulloblastoma","volume":"87","author":"Yi","year":"2018","journal-title":"Mol. Cell Neurosci."},{"key":"B169","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jcyt.2016.12.005","article-title":"Cord blood natural killer cells expressing a dominant negative TGF-beta receptor: Implications for adoptive immunotherapy for glioblastoma","volume":"19","author":"Yvon","year":"2017","journal-title":"Cytotherapy"},{"key":"B170","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40164-019-0153-x","article-title":"A high-throughput screening identifies histone deacetylase inhibitors as therapeutic agents against medulloblastoma","volume":"8","author":"Zhang","year":"2019","journal-title":"Exp. Hematol. Oncol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"e00043","DOI":"10.1002\/prp2.43","article-title":"NL-103, a novel dual-targeted inhibitor of histone deacetylases and hedgehog pathway, effectively overcomes vismodegib resistance conferred by Smo mutations","volume":"2","author":"Zhao","year":"2014","journal-title":"Pharmacol. Res. Perspect."},{"key":"B178","doi-asserted-by":"publisher","first-page":"vii106","DOI":"10.1093\/neuonc\/noac209.397","article-title":"A new Immunomodulatory function of pyrido-pyrimindine derivatives to impair metastatic group 3 medulloblastoma in vivo","volume":"24","author":"Zollo","year":"2022","journal-title":"Neuro-Oncology"},{"key":"B172","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10585-012-9473-5","article-title":"Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models","volume":"29","author":"Zollo","year":"2012","journal-title":"Clin. Exp. Metastasis"},{"key":"B173","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S1470-2045(13)70482-0","article-title":"Genetics of recurrent medulloblastoma","volume":"14","author":"Zollo","year":"2013","journal-title":"Lancet Oncol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s0959-8049(01)00355-0","article-title":"Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour\/medulloblastoma","volume":"38","author":"Zuzak","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"B175","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3389\/fped.2018.00370","article-title":"Application of small epigenetic modulators in pediatric medulloblastoma","volume":"6","author":"Zwergel","year":"2018","journal-title":"Front. Pediatr."},{"key":"B176","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1517\/17460441.2015.1038236","article-title":"Emerging approaches for histone deacetylase inhibitor drug discovery","volume":"10","author":"Zwergel","year":"2015","journal-title":"Expert Opin. Drug Discov."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1135404\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T23:36:41Z","timestamp":1678405001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1135404\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":175,"alternative-id":["10.3389\/fgene.2023.1135404"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2023.1135404","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"article-number":"1135404"}}